Practice points Some patients with early stage large cell neuroendocrine carcinoma of the lung will be ineligible for surgery. These patients will be managed with radiotherapy; either stereotactic ablative body radiotherapy (SABR) or conventionally fractionated radiation therapy. These patients are typically quite under represented on available lung SABR trials. This large national analysis showed that up to one third of such patients are managed with SABR.
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Articles by Athanasios Colonias
Stereotactic body radiation therapy in early-stage NSCLC: historical review, contemporary evidence and future implications
Stephen Abel, 1 Shaakir Hasan, 1 Zachary D Horne, 1 Athanasios Colonias, 1 and Rodney E Wegner* 1 Stephen Abel 1Allegheny Health Network Cancer Institute, Division of Radiation Oncology, Pittsburgh, PA, 15212, USA Shaakir Hasan 1Allegheny Health Network Cancer Institute, Division of Radiation Oncology, Pittsburgh, PA, 15212, USA Zachary D Horne 1Allegheny Health Network Cancer Institute, Division of Radiation Oncology, Pittsburgh, PA, 15212, USA Athanasios Colonias 1Allegheny Health Network...
Stereotactic body radiation therapy in early-stage NSCLC: historical review, contemporary evidence and future implications
Practice points Current standard-of-care for early-stage, nonoperative NSCLC is stereotactic body radiation therapy (SBRT). SBRT is a noninvasive treatment involving the precise delivery of ablative dose radiation. Compared with fractionated radiation, SBRT achieves superior local control and survival. Prospective trials comparing surgical resection versus SBRT are currently accruing. Lung cancer screening and the obesity epidemic may increase the incidence of inoperable cases.
Lung Cancer
Request Username Can't sign in? Forgot your username? Enter your email address below and we will send you your username Username or Email: If the address matches an existing account you will receive an email with instructions to retrieve your username
Request Username Can't sign in? Forgot your username? Enter your email address below and we will send you your username Username or Email: If the address matches an existing account you will receive an email with instructions to retrieve your username
Request Username Can't sign in? Forgot your username? Enter your email address below and we will send you your username Username or Email: If the address matches an existing account you will receive an email with instructions to retrieve your username
Request Username Can't sign in? Forgot your username? Enter your email address below and we will send you your username If the address matches an existing account you will receive an email with instructions to retrieve your username
Request Username Can't sign in? Forgot your username? Enter your email address below and we will send you your username If the address matches an existing account you will receive an email with instructions to retrieve your username
Request Username Can't sign in? Forgot your username? Enter your email address below and we will send you your username If the address matches an existing account you will receive an email with instructions to retrieve your username
Dose Escalation and Associated Predictors of Survival with Consolidative Thoracic Radiotherapy in Extensive Stage Small Cell Lung Cancer (SCLC): A National Cancer Database (NCDB) Propensity-Matched Analysis
Publication HistoryPublished online: August 20, 2018Accepted: August 16, 2018; Received: July 25, 2018;
Show More
loading
Actions
Is this you?
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.Get in touch with Athanasios
Contact Athanasios, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack